---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-007827"
form_type: "8-K"
ticker: "MBOT"
cik: "0000883975"
company_name: "Microbot Medical Inc."
filed_at: "2026-02-24T23:59:59+00:00"
generated_at: "2026-05-16T00:59:41.962327+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Tampa General Hospital first in Florida to adopt Microbot's LIBERTY robotic system

## Summary
- Tampa General Hospital (TGH) becomes first Florida health system to adopt LIBERTY Endovascular Robotic System after FDA 510(k) clearance.
- LIBERTY is the only FDA-cleared single-use remotely operated robotic system for peripheral endovascular procedures.
- U.S. peripheral endovascular procedures market approximately 2.5 million annually, representing significant commercial opportunity.
- Limited market release began late 2025; full market release planned at SIR conference in April 2026.
- CEO Harel Gadot cites TGH's innovation culture as endorsement of LIBERTY's value and market relevance.

## SEC filing metadata
- accession: 0001493152-26-007827
- form_type: 8-K
- ticker: MBOT
- cik: 0000883975
- company_name: Microbot Medical Inc.
- filed_at: 2026-02-24T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.6
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/883975/000149315226007827/0001493152-26-007827-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/883975/000149315226007827/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-007827
- JSON: https://secwatch.observer/filing/0001493152-26-007827.json
- Plain text: https://secwatch.observer/filing/0001493152-26-007827.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.